Komori
Alfresa Holdings (2784) · FactFirst stated

Revenue and profit growth in the FY2019 wholesale business for prescription drugs and other products

First written in FY2019. . Latest entry: FY2019.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Revenue and profit growth in the wholesale business for prescription pharmaceuticals and other productsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2019First statedAnnual report

    「当セグメントの業績は、これらにより、売上高2兆3,271億99百万円(前期比1.5％増)、営業利益402億68百万円(同14.1％増)となりました。」

    医療用医薬品等卸売事業は増収増益となり、営業利益は前期比14.1％増加した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.